According to the literatures, patients with PDE, PLPBP deficiency, and PNPO deficiency would respond to pyridoxine, PLP, or a combination of both treatments (Heath et al., 2020). The gene discussed is PLPBP; the disease is hyperinsulinemic hypoglycemia, familial, 4.